SEC Comment Letter for VERU INC. (VERU) (CIK 0000863894) (VERU) — Aug 5, 2016

VERU INC. (VERU) (CIK 0000863894)
Date: Aug. 5, 2016 · CIK: 0000863894 · Accession: 0000000000-16-087400

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-13602

Date

May 18, 2016

Author

/s/ Pamela A. Long

Form

UPLOAD

Company

VERU INC. (VERU) (CIK 0000863894)

Letter

August 5 , 2016 Mr. O.B. Parrish Chairman and Chief Executive Officer The Female Health Company 515 N. State Street, Suite 2225 Chicago, IL 60654

Re: Female Health Co. Preliminary Proxy Statement on Schedule 14A Filed May 18, 2016 File No. 001-13602

Dear Mr. Parish :

We completed our review of your filing on July 26, 2016. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the acc uracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Pamela A. Long

Show Raw Text

August 5 , 2016

Mr. O.B. Parrish
Chairman and Chief Executive Officer
The Female Health Company
515 N. State Street, Suite 2225
Chicago, IL 60654

Re: Female Health Co.
 Preliminary Proxy Statement on Schedule 14A
Filed May 18, 2016
File No. 001-13602

Dear Mr. Parish :

We completed our review of your filing on July 26, 2016.  We remind you that our
comments or changes to disclosure in response to our comments do not foreclose the
Commission from taking any action with respect to the company or the filing and the company
may not assert staff comments as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United States.  We urge all persons who are
responsible for the acc uracy and adequacy of the disclosure in the filing to be certain that the
filing includes the information the Securities Exchange Act of 1934 and all applicable rules
require.

Sincerely,

        /s/ Pamela A. Long

Pamela A. Long
Assistant Director
Office of Manufacturing  and
Construction

SecProbe.io